
    
      There will be 3 groups of treatment; each group will consist of 43 subjects with the
      treatment regimens :

        -  Treatment I : 1 tablet of DLBS1033 490 mg thrice daily, after meal

        -  Treatment II : 1 tablet of aspirin 80 mg once daily, after meal

        -  Treatment III : 1 tablet of clopidogrel 75 mg once daily, after meal

      Bleeding profile (by measuring INR value, PT, and aPTT) and clinical outcome (by measuring
      Gadjah Mada Stroke Scale and Barthel Index) to evaluate the efficacy of the investigational
      drug will be performed at baseline and end of study (Month 3rd). General condition of the
      subjects will be followed-up every month over three months of study medication.

      Physiotherapy will be provided to the subjects by the assigned Physiotherapist.
    
  